Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) Revenue (2016 - 2026)

Champions Oncology (CSBR) has 16 years of Revenue data on record, last reported at $15.0 million in Q4 2025.

  • For Q4 2025, Revenue rose 11.46% year-over-year to $15.0 million; the TTM value through Oct 2025 reached $58.4 million, up 9.06%, while the annual FY2025 figure was $56.9 million, 13.54% up from the prior year.
  • Revenue reached $15.0 million in Q4 2025 per CSBR's latest filing, up from $14.0 million in the prior quarter.
  • Across five years, Revenue topped out at $17.0 million in Q1 2025 and bottomed at $10.6 million in Q2 2021.
  • Average Revenue over 5 years is $13.0 million, with a median of $13.0 million recorded in 2022.
  • Peak YoY movement for Revenue: dropped 18.96% in 2023, then skyrocketed 41.77% in 2025.
  • A 5-year view of Revenue shows it stood at $11.8 million in 2021, then grew by 21.17% to $14.3 million in 2022, then decreased by 18.96% to $11.6 million in 2023, then grew by 16.56% to $13.5 million in 2024, then increased by 11.46% to $15.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Revenue were $15.0 million in Q4 2025, $14.0 million in Q3 2025, and $12.4 million in Q2 2025.